|
|
||||||||
Ann Thorac Surg 2007;84:221-224
© 2007 The Society of Thoracic Surgeons
a Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
b Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Accepted for publication March 13, 2007.
* Address correspondence to Dr Kim, 50 Ilwon-Dong, Kangnam-Ku, Seoul, 135-710, Republic of Korea (Email: jkim{at}smc.samsung.co.kr).
Background: Owing to the rarity of inflammatory myofibroblastic tumor, its pathology and clinical course are poorly understood.
Methods: We performed a retrospective chart review of patients diagnosed with inflammatory myofibroblastic tumor in the chest who underwent surgical resection.
Results: From 1995 to 2006, 15 patients (10 males and 5 females) underwent surgical procedures owing to inflammatory myofibroblastic tumors. The mean age of these patients was 31.3 years (range, 7 months to 61 years). Among them, 13 patients (86.7%) presented with respiratory symptoms such as cough, dyspnea, and hemoptysis. Seven patients presented with the tumor located in the lung parenchyma, 4 in the trachea, 2 in the main bronchus, 1 in the segmental bronchus, and 1 in the chest wall. The diagnosis was confirmed before surgery for only 1 patient (6.3%). The types of operations performed included lobectomies for 4 patients, wedge resections using video-assisted thoracic surgery for 4 patients, tracheal/bronchial resections with end-to-end anastomoses for 6 patients, and chest wall resection for 1 patient. Only 2 patients received adjuvant radiation therapy. We followed up with all patients postoperatively for a mean of 33.3 months (range, 1.2 months to 8.4 years). Fourteen patients were free of local recurrence or distant metastasis during the follow-up period.
Conclusions: Inflammatory myofibroblastic tumor usually requires surgical resection for both proper diagnosis and adequate treatment. Complete resection and achieving negative margins leads to excellent outcome.
This article has been cited by other articles:
![]() |
P. A. Thistlethwaite, J. Renner, D. Duhamel, S. Makani, G. Y. Lin, S. W. Jamieson, and J. Harrell Surgical Management of Endobronchial Inflammatory Myofibroblastic Tumors Ann. Thorac. Surg., February 1, 2011; 91(2): 367 - 372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |